West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
331.04
-5.99 (-1.78%)
Feb 4, 2025, 4:00 PM EST - Market closed
WST Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for WST stock have an average target of 430.2, with a low estimate of 355 and a high estimate of 536. The average target predicts an increase of 29.95% from the current stock price of 331.04.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for WST stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 | Jan '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 4 |
| Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Strong Buy Initiates $400 | Strong Buy | Initiates | $400 | +20.83% | Jan 8, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $350 → $355 | Strong Buy | Maintains | $350 → $355 | +7.24% | Dec 13, 2024 |
| Wolfe Research | Wolfe Research | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Dec 13, 2024 |
| UBS | UBS | Hold → Strong Buy Upgrades $350 → $390 | Hold → Strong Buy | Upgrades | $350 → $390 | +17.81% | Dec 12, 2024 |
| UBS | UBS | Hold Maintains $400 → $375 | Hold | Maintains | $400 → $375 | +13.28% | Feb 16, 2024 |
Financial Forecast
Revenue This Year
2.91B
from 2.95B
Decreased by -1.25%
Revenue Next Year
3.08B
from 2.91B
Increased by 5.66%
EPS This Year
6.67
from 7.88
Decreased by -15.36%
EPS Next Year
7.51
from 6.67
Increased by 12.66%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.0B | 3.3B | 3.7B | ||
| Avg | 2.9B | 3.1B | 3.3B | ||
| Low | 2.8B | 2.9B | 3.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 3.0% | 12.2% | 18.9% | ||
| Avg | -1.2% | 5.7% | 8.7% | ||
| Low | -4.4% | 0.2% | 2.1% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2028 |
|---|---|---|---|---|
| High | 7.06 | 8.10 | 9.82 | |
| Avg | 6.67 | 7.51 | 8.86 | |
| Low | 5.94 | 6.92 | 7.96 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2028 |
|---|---|---|---|---|
| High | -10.5% | 21.4% | 30.7% | |
| Avg | -15.4% | 12.7% | 17.9% | |
| Low | -24.6% | 3.7% | 5.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.